当前位置:首页 - 行情中心 - 博迅生物(920504) - 财务分析

博迅生物

(920504)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

博迅生物(920504)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.04亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益19512.80万元,未分配利润1859.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产24528.14万元,负债5015.35万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入52,515,393.6723,152,939.5122,161,362.9884,213,151.32
营业总成本47,789,310.2320,703,452.66109,497,810.7677,306,703.9
其他经营收益
营业利润4,192,679.041,446,130.0218,370,146.279,557,241.7
利润总额3,937,732.21,460,929.7918,111,992.119,164,828.2
净利润3,636,385.821,239,648.3315,810,441.428,175,893.45
每股收益
其他综合收益----
综合收益总额3,636,385.821,239,648.3315,810,441.428,175,893.45
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计153,480,064.2167,175,314.31174,703,160.23184,696,788.75
非流动资产:
非流动资产合计91,801,373.0878,762,629.7677,140,395.7673,011,839.57
资产总计245,281,437.28245,937,944.07251,843,555.99257,708,628.32
流动负债:
流动负债合计30,109,802.6531,599,370.6538,709,940.1144,247,596.46
非流动负债:
非流动负债合计20,043,654.919,440,676.1819,475,366.9720,937,365.92
负债合计50,153,457.5551,040,046.8358,185,307.0865,184,962.38
所有者权益(或股东权益):
归属于母公司股东权益合计195,127,979.73194,897,897.24193,658,248.91192,523,665.94
股东权益合计195,127,979.73194,897,897.24193,658,248.91192,523,665.94
负债和股东权益合计245,281,437.28245,937,944.07251,843,555.99257,708,628.32
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计30,470,210.917,637,068.23116,477,453.466,736,058.89
经营活动现金流出小计42,087,430.3920,031,509.0196,702,338.2274,512,796.57
经营活动产生的现金流量净额-11,617,219.48-12,394,440.7819,775,115.18-7,776,737.68
投资活动产生的现金流量:
投资活动现金流入小计143,430,387.2156,390,512.56280,751,669.76187,820,662.64
投资活动现金流出小计176,294,385.8782,999,772.76305,779,351.06260,258,529.72
投资活动产生的现金流量净额-32,863,998.66-26,609,260.2-25,027,681.3-72,437,867.08
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计2,279,999-26,278,227.339,265,674.95
筹资活动产生的现金流量净额-2,279,999--26,278,227.33-9,265,674.95
汇率变动对现金及现金等价物的影响4,253.3626.69-3,101.11-6,026.08
现金及现金等价物净增加额-46,756,963.78-39,003,674.29-31,533,894.56-89,486,305.79
期末现金及现金等价物余额29,676,167.437,429,456.8976,433,131.1818,480,719.95
补充资料:
现金及现金等价物的净增加额-46,756,963.78--31,533,894.56-
TOP↑